Source: Pancreatology. Conference titles: Joint Meeting of the International Association of Pancreatology (IAP). Unidade: FM
Subjects: NEOPLASIAS PANCREÁTICAS (TERAPIA), PROGNÓSTICO, FARMACOTERAPIA, METASTASE, INCIDÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORIOKA, C. Y et al. Is antisense oligonucleotides targeting K-ras point mutation a promise in the pancreatic cancer treatment in Syrian golden hamsters in vitro and in vivo?. Pancreatology. Basel: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 06 nov. 2024. , 2004APA
Morioka, C. Y., Machado, M. C. C., Saito, S., Yamago, G. I., Nakada, Y., Godoy, R. S. de, et al. (2004). Is antisense oligonucleotides targeting K-ras point mutation a promise in the pancreatic cancer treatment in Syrian golden hamsters in vitro and in vivo? Pancreatology. Basel: Faculdade de Medicina, Universidade de São Paulo.NLM
Morioka CY, Machado MCC, Saito S, Yamago GI, Nakada Y, Godoy RS de, Matheus AS, Jukemura J, Bacchella T, Filho DP, Watanabe A. Is antisense oligonucleotides targeting K-ras point mutation a promise in the pancreatic cancer treatment in Syrian golden hamsters in vitro and in vivo? Pancreatology. 2004 ; 4( 3-4): 330.[citado 2024 nov. 06 ]Vancouver
Morioka CY, Machado MCC, Saito S, Yamago GI, Nakada Y, Godoy RS de, Matheus AS, Jukemura J, Bacchella T, Filho DP, Watanabe A. Is antisense oligonucleotides targeting K-ras point mutation a promise in the pancreatic cancer treatment in Syrian golden hamsters in vitro and in vivo? Pancreatology. 2004 ; 4( 3-4): 330.[citado 2024 nov. 06 ]
